Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Régulier

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Annales De Biologie Clinique|July 27, 2001
[Molecular basis of oncogenesis]S Paul, E Régulier
Annales De Biologie Clinique|April 9, 2002
[Tumor-induced immunosuppression]S Paul, B Calmels, E Régulier
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Cost of a Pulmonary Arterial Hypertension-Related Hospitalization in BelgiumP Chevalier, J De Beule, M Lamotte, et al.
Human Gene Therapy|November 13, 2002
Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's diseaseE Régulier, L Pereira de Almeida, B Sommer, et al.
Gene Therapy|May 18, 1999
Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblastsE Régulier, B L Schneider, N Déglon, et al.
Human Gene Therapy|February 7, 1998
A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tensionC Rinsch, E Régulier, N Déglon, et al.
Cancer Gene Therapy|February 24, 2001
Adenovirus-mediated delivery of antiangiogenic genes as an antitumor approachE Régulier, S Paul, M Marigliano, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Annales De Biologie Clinique|July 27, 2001
[Molecular basis of oncogenesis]S Paul, E Régulier
Annales De Biologie Clinique|April 9, 2002
[Tumor-induced immunosuppression]S Paul, B Calmels, E Régulier
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Cost of a Pulmonary Arterial Hypertension-Related Hospitalization in BelgiumP Chevalier, J De Beule, M Lamotte, et al.
Human Gene Therapy|November 13, 2002
Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's diseaseE Régulier, L Pereira de Almeida, B Sommer, et al.
Gene Therapy|May 18, 1999
Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblastsE Régulier, B L Schneider, N Déglon, et al.
Human Gene Therapy|February 7, 1998
A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tensionC Rinsch, E Régulier, N Déglon, et al.
Cancer Gene Therapy|February 24, 2001
Adenovirus-mediated delivery of antiangiogenic genes as an antitumor approachE Régulier, S Paul, M Marigliano, et al.
Pageof 1